Dry Eye Disease
Pipeline by Development Stage
Drug Modality Breakdown
On Market (1)
Approved therapies currently available
Competitive Landscape
17 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 45 trials with date data
Clinical Trials (45)
Total enrollment: 4,390 patients across 45 trials
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult Participants With Dry Eye Disease
A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
A Study Designed to Evaluate Tear Production
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
A Phase 3 Study to Evaluate AZR-MD-001 in Patients with Abnormal Meibomian Gland Function and Dry Eye Disease (DED)
Safety and Efficacy of ST-100 (Vezocolmitide) Ophthalmic Solution 60 μg/ml Ophthalmic Solution in Subjects Diagnosed With Dry Eye Disease (DED)
A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants
Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
Safety Study of Tivanisiran to Treat Dry Eye
Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome
Effect of NOV03 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Mojave Study)
HELIX, a Double-masked Study of SYL1001 in Patients With Moderate to Severe Dry Eye Disease (DED)
Study of Diquafosol Tetrasodium Ophthalmic Solution in Subjects With Dry Eye Disease
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
Study of INS365 Ophthalmic Solution in Subjects With Dry Eye Disease
Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
Safety and Efficacy of Licaminlimab Ophthalmic Solution for the Treatment of Dry Eye Disease
Effectiveness of Diquafosol Prophylactic Therapy to Prevent Dry Eye Disease for Cataract Surgery Patients in Indonesia
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
Study of ST-100 as Treatment for Dry Eye Disease
Efficacy and Safety of PL9643 Ophthalmic Solution in Subjects With Dry Eye
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time
Efficacy Study of Ecabet Ophthalmic Solution in Dry Eye Disease
A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease
A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic Solution
A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye Disease
Study to Assess Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of Palovarotene Ophthalmic Solution in Healthy Adult Subjects
Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease
An Evaluation of the Safety and Tolerability of Ocular Lubricants
Efficacy and Safety of BUFY02 Versus TRB02 in the Treatment of Dry Eye Disease
Evaluation of the Safety and Tolerability of Ocular Lubricants
The Pattern of Dry Eye Disease After Cataract Surgery
Feasibility of IPL Combined With RF for Treatment of DED Due to MGD
Comparison of Two Types of Artificial Tears
Safety of Tinted Soft Scleral Eye Shields When IPL is Applied on Eyelids
Systane Complete Multi-symptom Relief
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
Evaluation of Ocular Comfort With ISTA Tears vs Systane
Systane Ultra Versus Maxidex Versus Saline